Immunotoxicity test in which lymphoid tissue or blood that has been treated with a test compound is co-incubated with target cells. The cytotoxic effect on target cells is measured, e.g., with the chromium release assay. It is used under circumstances where differences from untreated cells are attributed to natural killer (NK) cell activity.